Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
GENOSKIN logo — Redefining Non-Clinical Research with Live Human Skin

GENOSKIN

Redefining Non-Clinical Research with Live Human Skin

Founded 2011 United States Salem, United States 44 employees Venture round Total: $8.70M Biopharma, Biotechnology +2

General Information

Company Name GENOSKIN
Founded Year 2011
Location United States Salem, United States
Employees 44
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with GENOSKIN. To contact GENOSKIN, visit genoskin.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GENOSKIN compare?

A PDF of GENOSKIN and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GENOSKIN soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GENOSKIN

GENOSKIN is a groundbreaking startup in the biopharma, biotechnology, health care, and pharmaceutical industries, founded in 2011. The company's slogan, "First-in-human data to accelerate drug development," reflects its mission to revolutionize the early phase development of biotherapeutics, vaccines, medical devices, and cosmetics. GENOSKIN sources ethically-derived human skin from plastic surgeries, offering a more ethical and reliable alternative to animal experimentation. Utilizing advanced technologies and customizable ex-vivo human skin models, GENOSKIN provides precise insights into substance interactions, predicting absorption and irritation effects. Recent advancements in transcriptomic analysis and spatial biology capabilities have enabled the comprehensive understanding of substance effects at molecular and cellular levels. As a United States-based startup, GENOSKIN has the potential to have a significant impact on biomedical research and product development across various industries. As of now, specific information about the latest investment and investors is not available, but given the innovative nature of the company and the pressing need for ethical and effective alternatives in research and development, GENOSKIN presents an intriguing opportunity for potential future investors.

Business keywords: Drug development, First-in-human data, Human skin models, Pharmaceuticals, Cosmetics, Immunocompetent models, Topical administration, Systemic administration, Subcutaneous injections, Skin reactions, Immune response, Regulatory compliance, Ethical regulations, Quality control

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture round $8.70M 8
Bpifrance Crédit Agricole BNP Paribas
Bpifrance, Crédit Agricole +6
16 Sep 2025

Latest News

View All
Genoskin raises $8.7M to advance human skin models as animal testing alternative — Tech
Genoskin raises $8.7M to advance human skin models as animal testing alternative
Tech Sep 16, 2025

GENOSKIN Alternatives & Competitors

View All Alternatives
GENOSKIN vs
ASolution Pharmaceuticals Pvt. Ltd.
ASolution Pharmaceuticals Pvt. Ltd. India

Solving Pharma Challenges

102 employees
Biotechnology, Industrial
Compare GENOSKIN vs ASolution Pharmaceuticals Pvt. Ltd.
GENOSKIN vs
ValitaCell
ValitaCell Ireland

We create pioneering analytical technologies for quality control and performance for the biopharmace...

Grant
6 employees
Biotechnology, Health Care
Compare GENOSKIN vs ValitaCell
GENOSKIN vs
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. United States

Changing the landscape in life-threatening diseases

Post-IPO Debt
127 employees
Biopharma, Biotechnology
View all alternatives

FAQ About GENOSKIN

Redefining Non-Clinical Research with Live Human Skin
GENOSKIN was founded in 2011.
GENOSKIN is headquartered in Salem, United States.
GENOSKIN operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Drug development, First-in-human data, Human skin models and Pharmaceuticals.
GENOSKIN has approximately 44 employees.
GENOSKIN has completed 1 funding round, raising a total of $8.70M. The latest funding stage is Venture round.
Top alternatives and competitors to GENOSKIN include ASolution Pharmaceuticals Pvt. Ltd., ValitaCell, Reata Pharmaceuticals, Inc., Helsinn Group, XSPRAY PHARMA AB (PUBL). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GENOSKIN and ASolution Pharmaceuticals Pvt. Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GENOSKIN, https://bouncewatch.com/company/genoskin, updated 16 September 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout